Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrodotoxin for acute heroin withdrawal
ChiCTR-TRC-12002637Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tetrodotoxin in opioid withdrawal and heroin addiction (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Severity of withdrawal symptoms. Started Dec 2008; status: completed.
02
Drugs
tetrodotoxin
03
Conditions
opioid withdrawalheroin addiction
Beyond the preview
Go deeper on ChiCTR-TRC-12002637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002637.